Takeda inaugurates new R&D cell therapy manufacturing facility in US
This article was originally published here
Situated at the company’s R&D headquarters in Boston, the new facility offers end-to-end research and development services to advance the development of next-generation cell therapies. The new R&D
The post Takeda inaugurates new R&D cell therapy manufacturing facility in US appeared first on Pharmaceutical Business review.
Leave a Reply
Want to join the discussion?Feel free to contribute!